Min Ji Selected Research

Min Ji Research Topics

Disease

46	Neoplasms (Cancer) 02/2024 - 09/2003
12	Cataract (Cataracts) 02/2024 - 01/2019
9	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2022 - 01/2012
8	Leukemia 01/2023 - 03/2008
7	AIDS-Related Complex (ARC) 12/2023 - 01/2022
6	Neoplasm Metastasis (Metastasis) 06/2022 - 09/2012
5	Parkinson Disease (Parkinson's Disease) 11/2023 - 01/2022
5	Ocular Hypertension (Glaucoma, Suspect) 07/2023 - 09/2012
5	Breast Neoplasms (Breast Cancer) 12/2022 - 12/2013
5	Shock 10/2022 - 01/2016
5	Hemorrhage 11/2019 - 09/2003
4	Gliosis 01/2018 - 09/2012
3	Inflammation (Inflammations) 03/2024 - 01/2015
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2023 - 01/2020
3	Glaucoma 07/2023 - 12/2013
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2023 - 01/2022
3	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2023 - 01/2022
3	Glioma (Gliomas) 01/2022 - 11/2017
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2018 - 01/2012
3	Prostatic Neoplasms (Prostate Cancer) 08/2015 - 01/2007
2	Abdominal Aortic Aneurysm 03/2024 - 11/2019
2	Arthrogryposis renal dysfunction cholestasis syndrome 12/2023 - 10/2022
2	Epiretinal Membrane (Epiretinal Membranes) 11/2023 - 01/2022
2	Alzheimer Disease (Alzheimer's Disease) 02/2023 - 01/2019
2	Pathologic Complete Response 01/2023 - 05/2012
2	Pathologic Processes 10/2022 - 05/2016
2	Dyskinesias (Dyskinesia) 06/2022 - 01/2022
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2022 - 08/2019
2	Substance-Related Disorders (Drug Abuse) 01/2022 - 01/2021
2	Hyperthermia 06/2020 - 01/2020
2	Carcinogenesis 01/2020 - 02/2009
2	Astigmatism 01/2020 - 01/2019
2	Colonic Neoplasms (Colon Cancer) 01/2019 - 08/2015
2	Hyperlipidemias (Hyperlipidemia) 04/2018 - 07/2015
2	Hypoxia (Hypoxemia) 01/2016 - 11/2006
2	Myeloid Leukemia (Leukemia, Myelocytic) 01/2015 - 01/2012
2	Starvation 09/2014 - 11/2008
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 09/2014 - 06/2011

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 11/2023 - 11/2004
7	Retinaldehyde (Retinal)IBA 07/2023 - 09/2012
5	CytokinesIBA 01/2022 - 01/2012
4	Interleukin-10 (Interleukin 10)IBA 11/2023 - 05/2012
4	Messenger RNA (mRNA)IBA 11/2023 - 01/2020
4	MicroRNAs (MicroRNA)IBA 11/2023 - 02/2009
4	Liposomes (Liposome)IBA 01/2023 - 01/2019
4	Fluorescent Dyes (Fluorescent Probes)IBA 01/2023 - 04/2017
4	Biomarkers (Surrogate Marker)IBA 11/2022 - 06/2011
4	GossypolIBA 08/2015 - 11/2004
3	Long Noncoding RNAIBA 03/2024 - 11/2023
3	Capsules (Microcapsules)IBA 11/2023 - 06/2020
3	LipidsIBA 01/2023 - 07/2015
3	Peptides (Polypeptides)IBA 01/2023 - 09/2005
3	Dexamethasone (Maxidex)FDA LinkGeneric 01/2023 - 01/2022
3	Levodopa (L Dopa)FDA LinkGeneric 06/2022 - 01/2022
3	LigandsIBA 01/2022 - 04/2017
3	EnzymesIBA 10/2020 - 05/2012
3	ProdrugsIBA 01/2020 - 03/2014
3	AntigensIBA 01/2020 - 03/2008
3	Glial Fibrillary Acidic ProteinIBA 01/2018 - 09/2012
2	HMGB1 Protein (HMG1)IBA 03/2024 - 07/2014
2	RNA (Ribonucleic Acid)IBA 12/2023 - 08/2015
2	6-methyladenineIBA 12/2023 - 01/2023
2	N-methyladenosineIBA 12/2023 - 01/2023
2	Immune Checkpoint InhibitorsIBA 11/2023 - 06/2022
2	Opioid Analgesics (Opioids)IBA 10/2023 - 01/2022
2	Glucose (Dextrose)FDA LinkGeneric 09/2023 - 01/2005
2	thiamine triphosphorate (TTP)IBA 03/2023 - 01/2019
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 12/2015
2	VaccinesIBA 01/2022 - 06/2007
2	Dopamine D3 ReceptorsIBA 01/2022 - 01/2021
2	Morphine (MS Contin)FDA LinkGeneric 01/2022 - 01/2021
2	Naloxone (Narcan)FDA LinkGeneric 01/2022 - 01/2021
2	chromium hexavalent ionIBA 10/2021 - 01/2021
2	InterleukinsIBA 01/2021 - 05/2012
2	Heavy MetalsIBA 01/2021 - 01/2016
2	Hormones (Hormone)IBA 01/2021 - 07/2008
2	Ferrosoferric Oxide (Magnetite)FDA Link 06/2020 - 04/2018
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2020 - 01/2019
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2020 - 08/2015
2	Antineoplastic Agents (Antineoplastics)IBA 01/2020 - 11/2018
2	AcidsIBA 01/2020 - 11/2018
2	Imatinib Mesylate (Gleevec)FDA Link 01/2018 - 02/2016
2	WastewaterIBA 01/2017 - 11/2008
2	Chemokine ReceptorsIBA 01/2017 - 01/2015
2	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 12/2016 - 01/2016
2	3,4-dihydroxyphenylglycolIBA 12/2016 - 01/2016
2	ImmunosorbentsIBA 01/2015 - 05/2012
2	Dasatinib (BMS 354825)FDA Link 05/2013 - 01/2012
2	Gefitinib (Iressa)FDA Link 12/2011 - 06/2010
1	Nanoparticle Drug Delivery SystemIBA 02/2024

Therapy/Procedure

16	Therapeutics 02/2024 - 09/2003
12	Drug Therapy (Chemotherapy) 11/2023 - 11/2004
4	Phacoemulsification 02/2024 - 01/2019
3	Lasers (Laser) 02/2024 - 01/2020
3	Radiotherapy 06/2022 - 03/2016
3	Intravitreal Injections 01/2018 - 01/2016
2	Enterostomy 11/2023 - 01/2020
2	Induction Chemotherapy 01/2023 - 11/2022
2	Photothermal Therapy 11/2022 - 05/2022
2	Stents 01/2021 - 11/2019